Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet regimen for managing HIV infection. This drug integrates three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the HIV's ability to copy within the body, considerably decreasing the viral burden. For many individ